Evidence map›Paper›PMID 39311319›Full record

ArticleVision (Basel, Switzerland)2024

Objective Refraction Status before and after Cycloplegia: From Childhood to Young Adulthood.

Karola Panke, Megija Jorova

Abstract read
In one paragraph

Article in Vision (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Karola PankeDepartment of Optometry and Vision Science, University of Latvia, Jelgavas Street 1, LV-1004 Riga, Latvia.ORCID 0000-0002-1120-0783
Megija JorovaDepartment of Optometry and Vision Science, University of Latvia, Jelgavas Street 1, LV-1004 Riga, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the clinical information revealed after cycloplegia and assess how age and non-cycloplegic refractive status influence the classification of types of refractive error, as well as the relationship between age and cycloplegia-induced changes in the power of refractive errors. We analysed the records of 472 non-population-based ophthalmology practice patients aged 3-28 years (mean ± SD: 9.1 ± 4.6). Cycloplegia was induced with one drop of cyclopentolate 1% in each eye, and eye refraction was measured 30 ± 5 min later using an objective autorefractometer. Cycloplegia induced a clinically significant (≥0.50 D) hyperopic shift in the spherical equivalent of 60.2% of participants and a myopic shift in 1%, resulting in a 34.1% increase in the frequency of participants with hyperopia, while the frequency of those with myopia and emmetropia decreased by 5.5% and 23.3%, respectively. The average spherical equivalent difference (mean ± SD) induced by cycloplegia was 0.72 ± 0.73 D, with the highest difference observed in the 3-5 years age group (1.18 ± 0.85 D). The differences in astigmatism power (

Indexed as

autorefractometercyclopentolatecycloplegiaprevalencerefractive error

Identifiers

PMID39311319
PMCPMC11417856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.